B2H is the designated contact point to simplify and improve the access to a broad platform of healthcare solutions developed by medical and scientific research teams of the University Hospital of Liege and University of Liege in Belgium.
B2H aims to match the know-how of researchers, clinicians and technology managers with the needs of your organization.
Though our network of technological and scientific expertise, B2H can support projects at every stage from early discovery, through preclinical up to translational and personalized medicine.
Sector of activity:
Biobanks, Biomarkers / Biomarker Discovery, Business development, Cancer / Oncology, Cardiovascular, Dentistry, Drug Discovery / Research & Development, Gastroenterology, Gene / Cell Therapy, Genomics, Hematology, Imaging, Inflammation / Autoimmune Disorders, Metabolomics, Molecular biology, Musculoskeletal, Neurology /Central Nervous System, Nuclear medicine, Personalized Medicine, Pneumology, Proteomics, Regenerative Medicine, Respiratory / Asthma, Rheumatology, Toxicology, Transcriptomics, Translational medecine